Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treat

European Commission and MHRA approves transfer of marketing authorization from
Oasmia Pharmaceutical AB to Inceptua AB

Related Keywords

Norway ,Luxembourg ,Iceland ,Liechtenstein ,United Kingdom ,Switzerland ,Inceptua Pharma ,Nicole Anscombe Cox ,Clive Whitcher ,Stefan Fraenkel ,Elevar Therapeutics Inc ,Dear Editorial Team ,European Commission ,Inceptua Group ,Regulatory Agency ,Editorial Team ,United Kingdom Medicines ,Oasmia Pharmaceutical ,Life Science Newswire ,Chief Executive Officer ,Elevar Therapeutics ,Harma Ovarian Cancer Treatment Zenopa ,